Skip to main content

Advertisement

SpringerLink
Log in

Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

This study investigated the usefulness of serum antimüllerian hormone (AMH) measurements at two distinct menstrual cycle phases to predict in vitro fertilization (IVF) outcomes.

Methods

This was a prospective observational study enrolling 135 consecutive patients referred for conventional IVF or ICSI in a university hospital. Blood samples were obtained for serum AMH measurements on days 3 and 18–20, while transvaginal ultrasound was performed for antral follicle count (AFC) at day 3 of the menstrual cycle immediately before treatment. AMH was measured with the new Beckman Coulter Generation II (GenII) assay. The main outcome measures were cycle cancellation due to poor ovarian response, clinical pregnancy, and live birth.

Results

There was a strong correlation between AMH levels measured at day 3 and day 18–20 of the menstrual cycle (r = 0.837; P < 0.0001). Day 18–20 serum AMH was comparable to day 3 serum AMH and AFC for the prediction of cycle cancellation (areas under the ROC curve were 0.84 for day 3 AMH, 0.89 for day 18–20 AMH, and 0.80 for AFC). Day 18–20 AMH had a modest predictive value for pregnancy or live birth (area under ROC curve 0.71 for both), which was comparable to that of day 3 AMH; however, AFC had no predictive value for these outcomes.

Conclusions

Day 18–20 AMH was comparable to day 3 AMH for the prediction of cycle cancellation, clinical pregnancy, and live birth after IVF. Both AMH measurements were accurate for the prediction of cancellation but were significantly less useful for the prediction of pregnancy or live birth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, et al. Isolation of the bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45:685–98.

    Article  PubMed  CAS  Google Scholar 

  2. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143:1076–84.

    PubMed  CAS  Google Scholar 

  3. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891–9.

    PubMed  CAS  Google Scholar 

  4. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131:1–9.

    Article  PubMed  CAS  Google Scholar 

  5. Andersen CY, Byskov AG. Estradiol and regulation of anti-mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles’ fluid. J Clin Endocrinol Metab. 2006;91:4064–9.

    Article  PubMed  CAS  Google Scholar 

  6. Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol. 2012;10:9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-mullerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150:166–70.

    Article  PubMed  CAS  Google Scholar 

  8. Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98:1107–14.

    Article  PubMed  CAS  Google Scholar 

  9. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17:46–54.

    Article  PubMed  CAS  Google Scholar 

  10. Hsu A, Arny M, Knee AB, Bell C, Cook E, Novak AL, et al. Antral follicle count in clinical practice: analyzing clinical relevance. Fertil Steril. 2011;95:474–9.

    Article  PubMed  Google Scholar 

  11. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2012;98:1407–15

  12. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.

    Article  PubMed  Google Scholar 

  13. Celik E, Bastu E, Dural O, Yasa C, Buyru F. Relevance of anti-mullerian hormone on in vitro fertilization outcome. Clin Exp Obstet Gynecol. 2013;40:66–9.

    PubMed  CAS  Google Scholar 

  14. Lee TH, Liu CH, Huang CC, Hsieh KC, Lin PM, Lee MS. Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles. Reprod Biol Endocrinol. 2009;7:100.

    Article  PubMed  PubMed Central  Google Scholar 

  15. La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, et al. Anti-mullerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed online. 2011;22:341–9.

    Article  PubMed  Google Scholar 

  16. Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Role of baseline antral follicle count and anti-mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. PLoS One. 2013;8:e61095.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, et al. Antral follicle count determines poor ovarian response better than anti-mullerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30:657–65.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2013;168:173–7.

    Article  PubMed  Google Scholar 

  19. Khader A, Lloyd SM, McConnachie A, Fleming R, Grisendi V, La Marca A, et al. External validation of anti-mullerian hormone based prediction of live birth in assisted conception. J Ovarian Res. 2013;6:3.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22:1837–40.

    Article  PubMed  CAS  Google Scholar 

  21. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21:3103–7.

    Article  PubMed  Google Scholar 

  22. La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod. 2007;22:766–71.

    Article  PubMed  Google Scholar 

  23. Elgindy EA, El-Haieg DO, El-Sebaey A. Anti-mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril. 2008;89:1670–6.

    Article  PubMed  CAS  Google Scholar 

  24. Rosen MP, Johnstone E, Addauan-Andersen C, Cedars MI. A lower antral follicle count is associated with infertility. Fertil Steril. 2011;95:1950–4. 4 e1.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gleicher N, Weghofer A, Barad DH. Anti-mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010;94:2824–7.

    Article  PubMed  CAS  Google Scholar 

  26. Celik H, Bildircin D, Guven D, Cetinkaya MB, Alper T, Batuoglu AS. Random anti-mullerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-mullerian hormone in poor responders in assisted reproductive treatment. J Assist Reprod Genet. 2012;29:797–802.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nelson SM, Iliodromiti S, Fleming R, Anderson R, McConnachie A, Messow CM. Reference range for the antimullerian hormone generation II assay: a population study of 10,984 women, with comparison to the established diagnostics systems laboratory nomogram. Fertil Steril. 2014;101:523–9.

    Article  PubMed  CAS  Google Scholar 

  28. Ledger WL. Measurement of antimullerian hormone: not as straightforward as it seems. Fertil Steril. 2014;101:339.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Research supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Federal University of Minas Gerais, and National Institute of Hormones and Women’s Health, Av. Prof. Alfredo Balena 110, 9 andar, 30130-100, Belo Horizonte, MG, Brazil

    Carolina P. Rezende, Ana L. Rocha, Cynthia Dela Cruz, Lavinia E. Borges, Helen L. Del Puerto & Fernando M. Reis

Authors
  1. Carolina P. Rezende
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana L. Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cynthia Dela Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lavinia E. Borges
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Helen L. Del Puerto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernando M. Reis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fernando M. Reis.

Additional information

Capsule Day 18–20 serum AMH performed similarly to day 3 serum AMH and AFC for the prediction of cycle cancellation. AMH had a modest performance for predicting pregnancy or live birth, whereas AFC had no predictive value for these outcomes.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezende, C.P., Rocha, A.L., Dela Cruz, C. et al. Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization. J Assist Reprod Genet 31, 1303–1310 (2014). https://doi.org/10.1007/s10815-014-0289-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-014-0289-x

Keywords

Search

Navigation